-
CDK Related Products (477)
Related Products (477)
-
Toyocamycin (Standard)
0 ImagesCat. No.: HY-103248RCAS No.: 606-58-6Synonyms: Vengicide (Standard)DL-Aspartic acid (Standard) is the analytical standard of DL-Aspartic acid. This product is intended for research and analytical applications. DL-Aspartic acid (DL-Asp-OH) is a kind of biological materials or organic compounds that are widely used in life science research.
-
CDK8-IN-11 hydrochloride
0 ImagesCat. No.: HY-151463A
-
Cdk2/Cyclin Inhibitory Peptide II
0 ImagesCat. No.: HY-P3731CAS No.: 237392-85-7Cdk2/Cyclin Inhibitory Peptide II (Tat-LDL), a CDK2 inhibitor, kills U2OS osteosarcoma cells in a dose-dependent manner.
-
CDK1-IN-7
0 ImagesCat. No.: HY-176189CAS No.: 933009-51-9
-
CDK2-IN-14
0 ImagesCat. No.: HY-151580CAS No.: 2862836-22-2
-
Briciclib sodium
0 ImagesCat. No.: HY-16366ACAS No.: 865784-01-6Synonyms: ON 014185 sodiumBriciclib (ON 014185) sodium is a eukaryotic translation initiation factor 4E (eIF4E) inhibitor. Briciclib sodium exhibits broad-spectrum anti-cancer activity, including in mantle cell leukemia, breast cancer, gastric cancer, and esophageal cancer cells. Briciclib sodium reduces the expression of cyclin D1 and c-Myc, and enhances the expression of P53 and Cleaved Caspase 3 pro-apoptotic proteins. Briciclib sodium can be used for the study of hematological system tumors and solid tumors.
-
LQ23
0 ImagesCat. No.: HY-162398CAS No.: 2997615-62-8LQ23 is a selective inhibitor for CDC2-like kinase 2 (CLK2) with an IC50 of 1.4 nM. LQ23 exhibits anti-inflammatory activity.
![[pSer2, pSer5, pSer7]-CTD TFA](https://file.medchemexpress.com/product_pic/hy-p1933a.gif "Click to View [pSer2, pSer5, pSer7]-CTD TFA Product Detail")
-
CDK4-IN-2
0 ImagesCat. No.: HY-153443CAS No.: 2380320-68-1
-
CDK8-IN-9
0 ImagesCat. No.: HY-151255CAS No.: 2850253-95-9
-
Cdc7-IN-9
0 ImagesCat. No.: HY-143380CAS No.: 2649407-21-4Cdc7-IN-9 is a potent Cdc7 inhibitor and can be used for cancer research.
-
Antitumor agent-104
0 ImagesCat. No.: HY-155038CAS No.: 2245272-16-4
-
PARP-1/2-IN-2
0 ImagesCat. No.: HY-149398CAS No.: 3052304-23-8
-
EGFR/HER2/CDK9-IN-2
0 ImagesCat. No.: HY-147797CAS No.: 1180924-34-8
-
CDK4/6-IN-13
0 ImagesCat. No.: HY-146214CAS No.: 1908454-70-5As a cdk4/6 inhibitor. Compounds 10B and 10C showed low nanomolar activity, ideal antiproliferative activity, excellent metabolic properties and acceptable pharmacokinetics on cdk4/6.
-
MPT0L145
0 ImagesCat. No.: HY-122888CAS No.: 2070837-24-8MPT0L145 is a PIK3C3/FGFR inhibitor, with a Kd value of 0.53 nM for PIK3C3. MPT0L145 decreases the phosphorylation of FGFR1, FGFR3 and their downstream proteins (FRS2, ERK and Akt). MPT0L145 induces G0/G1 cell cycle arrest and decreased protein levels of cyclin E. MPT0L145 promotes mitochondrial dysfunction, ROS production, and DNA damage. MPT0L145 is an autophagy inhibitor. MPT0L145 significantly sensitizes cancer cells to targeted or chemotherapeutic agents. MPT0L145 can be used for cancer research, such as bladder cancer and NSCLC.
